Minority Investments and FDI Screening in France (2026): When a Non‑controlling Stake Triggers Notification

FDI screening minority investments france has become one of the most pressing compliance questions for cross‑border deal teams in 2026, and the reason is structural. France’s merger‑control notification thresholds continue to be set primarily by reference to turnover, and reforms under discussion may pull a growing number of transactions outside merger review, yet French foreign investment screening remains robust and, crucially, sector‑driven rather than size‑driven. The practical effect is a widening compliance blind spot: deals that no longer trigger competition filings may still require foreign direct investment authorisation, particularly where a minority stake carries governance rights or touches a sensitive sector.

In short, a non‑controlling stake in a French target can trigger FDI screening where the investor acquires special rights, gains access to sensitive assets or technology, or invests in a strategically protected industry. This guide sets out the triggers, the timelines, and the drafting techniques deal teams should use to manage signing, closing and conditionality.

Snapshot, the French FDI regime and who enforces it (french fdi screening 2026)

France operates one of the most developed foreign investment control regimes in Europe. The legal foundation sits in the Code monétaire et financier (notably Articles L. 151‑1 et seq. and R. 151‑1 et seq.), which establishes the state’s power to require prior authorisation for foreign investments in activities considered essential to national interests, defence, public security and public order. Implementing decrees and orders, published via Legifrance and the Journal Officiel, flesh out the list of protected sectors, the applicable thresholds and the procedural timelines.

The authority responsible for administering the regime is the Direction générale du Trésor (the French Treasury), acting under the Minister for the Economy. The Treasury receives notifications, conducts the substantive review, and issues authorisations, often with conditions attached. Its published guidance is the practical starting point for any deal team assessing exposure; the Direction générale du Trésor maintains dedicated foreign‑investment pages describing process, contacts and required information.

At EU level, Regulation (EU) 2019/452 establishes a cooperation framework for the screening of foreign direct investment into the Union. It does not replace national regimes but coordinates them, allowing member states and the Commission to comment on transactions that may affect security or public order across borders. France’s national screening operates within, and is reinforced by, this EU architecture.

It is essential to distinguish FDI screening from merger control. Merger control asks whether a transaction harms competition, and it is triggered by turnover thresholds. FDI screening asks whether a foreign investor gains influence over a strategically sensitive French activity, and it is triggered by the nature of the target’s business and the rights the investor acquires. A deal can be caught by one, both, or neither. Where reforms narrow the reach of competition review, the significance of FDI screening minority investments france scenarios grows correspondingly.

Do minority stakes trigger French FDI screening? A decision tree

The single most common misconception is that FDI screening only applies where an investor takes control. It does not. French rules are designed to catch influence, not merely majority ownership. The question of whether FDI screening minority investments france rules apply turns on three interlocking factors: the identity and nationality of the investor, the sector in which the target operates, and, critically for minority deals, the bundle of rights the investor acquires alongside the shares.

A useful way to think through exposure is a sequential decision tree:

1. Is the investor foreign? If the ultimate acquirer is controlled from outside France, screening may apply. Non‑EU/EEA investors face the broadest scrutiny; EU/EEA investors face a narrower but still real set of triggers in the most sensitive sectors.
2. Does the target carry on a protected activity? If the French target operates in defence, critical infrastructure, sensitive technologies, or another listed sector, the transaction is in scope for review. If it does not, screening generally does not apply regardless of stake size.
3. Does the stake or the accompanying rights cross a control or influence threshold? Even a small percentage can be caught where it confers governance rights, blocking powers, or access to sensitive assets. For non‑EU/EEA investors, French rules also capture the crossing of a defined voting‑rights threshold in listed companies (as set in the applicable implementing text). This is where minority stake review france most often bites.

If the answer to all three is yes, notification and prior authorisation are very likely required. If the target is not in a protected sector, the transaction usually escapes screening entirely, which is why sector mapping (below) is the first analytical step in any French deal.

Rights and indicia that convert a minority into a de facto controlling stake

The heart of FDI screening minority investments france analysis is identifying the rights that give an investor influence disproportionate to its economic stake. A 10% shareholding is unremarkable on its own; the same 10% coupled with a board seat and a veto over strategic decisions in a defence‑technology company is a different matter entirely. Regulators look through the cap table to the substance of governance. The following indicia frequently convert a passive minority into a notifiable position:

• Board representation. The right to appoint one or more directors, or to designate observers with access to board materials, signals influence over strategy.
• Veto and blocking rights. Vetoes over budgets, business plans, capital expenditure, asset disposals, or changes to the scope of activities give a minority holder the power to shape or obstruct strategic decisions.
• Blocking minorities. A stake large enough to block special resolutions can amount to negative control.
• Management appointment rights. Rights to appoint, remove or approve senior management, particularly a CEO or CTO, indicate operational influence.
• Access to sensitive assets. Contractual or governance rights granting access to sensitive intellectual property, R&D, source code, algorithms, classified data or dual‑use technology are a strong trigger, even where economic ownership is low.
• Concerted action. Where several investors act in concert under a shareholders’ agreement, their combined rights and holdings are assessed together, not individually.
• Convertible instruments and conversion rights. Instruments that convert into a controlling or influential position, or that carry attached governance rights, can bring a transaction into scope where the instrument confers present influence.
• Golden shares and special rights. Any share class carrying disproportionate voting or veto power is closely scrutinised.
• Contractual management or control. Service, licensing or supply arrangements that hand operational control to the investor can substitute for equity in the regulator’s analysis.

Common indicia that trigger review, matched to likely sectors

Each indicium carries more weight in some sectors than others. Practical markers to test against the target’s business include:

• Voting and veto rights tied to strategic decisions, most sensitive in defence, energy and critical infrastructure, where any capacity to obstruct national‑interest operations attracts scrutiny.
• Board representation and observer rights, heavily weighted in telecoms, energy networks and data centres, where board access can expose network architecture or security arrangements.
• Access to R&D, algorithms and source code, decisive in AI, semiconductors and biotech, where the technology itself is the protected asset.
• Vetoes over asset disposals and budgets, significant in critical infrastructure and transport, where control over capital allocation affects service continuity.
• Supply‑chain and operational control, relevant in health, dual‑use technology and semiconductors, where contractual leverage can equal equity control.

The practical lesson for minority stake review france is that the rights schedule of the shareholders’ agreement often matters more than the headline percentage. Deal teams should map every governance right against the target’s sector before assuming a deal is outside scope.

Who is caught? Nationals, EU/EEA investors and special cases

Investor nationality is a threshold filter that shapes, but does not fully determine, exposure. French rules distinguish between investors according to where control ultimately resides.

Non‑EU and non‑EEA investors face the broadest scrutiny. For them, a wide range of protected sectors and a comparatively low set of triggering thresholds bring transactions into review. Investors controlled from outside the Union should assume that any acquisition of governance rights, or the crossing of the applicable voting‑rights threshold, in a French target operating in a sensitive sector will require analysis.

EU and EEA investors are generally treated more favourably. The French regime historically applies a narrower list of triggering activities to investors established within the European Union or the European Economic Area. However, and this is the point deal teams most often miss, EU/EEA investors are not automatically exempt. In the most sensitive sectors, particularly those touching defence and national security, EU‑based investors can still be caught, and the substance of the investor’s rights matters more than nationality alone. The EU framework under Regulation (EU) 2019/452 expressly preserves member states’ ability to protect security and public order.

Two special cases warrant attention. First, the look‑through principle: where an EU/EEA vehicle is ultimately controlled by a non‑EU parent, regulators assess the ultimate beneficial owner, not the immediate acquirer. Structuring an acquisition through an EU holding company does not neutralise non‑EU status. Second, public‑interest and reciprocity considerations can influence the substantive review, particularly where the investor’s home state itself restricts inbound investment. The OECD’s comparative work on investment policy and screening documents the growing convergence of states towards sector‑focused, ownership‑transparent review, a trend France reflects.

Procedural steps, timelines and interaction with M&A signing and closing (fdi authorization france)

Once a transaction is identified as caught, the procedural pathway is prescriptive and its timing must be built into the deal calendar from the outset. The core sequence is: an optional preliminary request to the Treasury to confirm whether an activity falls within scope; formal notification and request for authorisation; a first‑phase examination during which the authority decides whether the transaction can be cleared (unconditionally or subject to conditions); and, where the deal raises national‑interest concerns, an in‑depth (second‑phase) review that may culminate in a conditional authorisation or, in rare cases, a refusal.

The regulatory clocks are set by the implementing decrees published on Legifrance, and deal teams should always confirm the current periods against the applicable text before committing to a timetable. As a planning matter, teams should prepare for a first‑phase review measured in weeks and an in‑depth review that can add further weeks or months where the target operates at the core of a sensitive sector or where conditions must be negotiated. Complex matters, those involving classified technology, multiple regulators, or conditions such as security undertakings, sit at the longer end of the range.

The interaction with signing and closing is the practical crux. French screening operates as a suspensory regime: closing must not occur before authorisation is obtained. Signing can and routinely does happen earlier, with authorisation structured as a condition precedent to completion. Implementing the transaction, transferring shares, exercising governance rights, or gaining access to sensitive assets, before clearance exposes the parties to remedial orders, including unwinding, and to sanctions. In practice, this means:

• Make FDI authorisation a condition precedent to closing. Draft it as an objective, clearly defined condition, and specify what constitutes satisfaction (unconditional clearance, or clearance on conditions acceptable to the buyer).
• Agree a reverse break fee scaled to regulatory risk. Where the buyer bears the regulatory risk, the seller may require compensation if authorisation fails; size the fee to the assessed probability of a problem.
• Set a realistic long‑stop date. Build in enough runway for both first‑phase and in‑depth review, plus a buffer, and provide a mechanism to extend where a review is ongoing.
• Include interim covenants and standstill obligations. Restrict the buyer from exercising influence, appointing directors or accessing sensitive information before clearance; hold‑separate and information‑firewall arrangements protect against premature implementation.
• Consider escrow of shares or consideration. Escrow mechanics can bridge the gap between signing and authorisation while protecting both parties.

Because the regime is suspensory, the temptation to grant a new investor early board access or information rights “to help integration planning” is a serious trap. Those very rights can constitute premature implementation of a notifiable transaction. Governance rights should be dormant until authorisation is in hand.

Pre‑filing engagement and the information to prepare

Preliminary engagement with the Treasury, including a request confirming whether the target’s activity is in scope, is often worthwhile: it can clarify exposure and surface likely concerns before the formal clock starts. To make that engagement productive, and to accelerate the formal review, deal teams should assemble the following ahead of filing:

• Corporate structure of the investor, including the full ownership chain up to the ultimate beneficial owner and any concert parties.
• Description of the target’s activities, mapped explicitly against the protected‑sector lists, with candour about any defence, dual‑use or critical‑infrastructure elements.
• Technology description, covering sensitive IP, R&D pipelines, algorithms and any classified or export‑controlled elements.
• Governance rights schedule, setting out board seats, vetoes, information rights and any special share rights the investor will hold.
• Business plan and rationale for the investment, including the investor’s intentions towards the target’s French operations and workforce.
• Employee and site information, particularly where facilities host sensitive activities.
• Cybersecurity and data‑protection controls, relevant where the target handles sensitive data or operates critical systems.

Structuring minority investments to avoid or mitigate a filing

Where a filing would be commercially damaging, because of timing, confidentiality or the risk of conditions, structuring can sometimes reduce or remove the trigger. The guiding principle is that FDI screening minority investments france analysis follows substance: the further an investor moves from influence and access, the lower the exposure. But regulators look through form to substance, so cosmetic restructuring rarely works. Genuine structuring options include limiting governance rights, taking non‑voting economic instruments, and deferring any influential rights until after authorisation.

Certain red lines remain regardless of structuring. Where the target sits at the core of a protected sector and the investor obtains any meaningful access to sensitive assets or any capacity to influence strategic decisions, regulators will intervene. Information firewalls, non‑voting preferred shares and contractual limits on concerted action can reduce exposure, but they cannot manufacture immunity where the substance of influence remains.

When structuring is impractical, negotiating SPA protections

For most strategic minority investments in sensitive sectors, avoiding the filing is neither possible nor desirable, and the better course is to allocate and manage regulatory risk in the SPA. A robust drafting checklist covers:

• Regulatory condition precedent. “Completion is conditional on obtaining FDI authorisation from the French Minister for the Economy, whether unconditional or subject to conditions reasonably acceptable to the Buyer.”
• Reverse break fee. “If Completion does not occur by the Long‑Stop Date solely because the FDI Condition is not satisfied, the Buyer shall pay the Seller a fee of [amount].”
• Long‑stop date and extension. “The Long‑Stop Date is [date], automatically extended by [period] where an FDI review remains pending.”
• Interim governance and standstill. Restrict pre‑clearance exercise of influence, board appointments and access to sensitive information.
• Cooperation covenants. Require both parties to prepare and submit the notification promptly, share information, and use best efforts to obtain clearance.
• Representations on notification. Warranties confirming the parties’ understanding of the regime and their obligation to cooperate with the authority.

Sector map 2026, sensitive sectors and the likelihood of scrutiny

Because sector determines scope, the first analytical step in any deal is mapping the target against the protected activities. The following table summarises typical exposure. It is indicative only; the definitive list and any recent amendments must be confirmed against the current implementing texts on Legifrance and against Treasury guidance and Ministry of Economy communications.

The 2026 nuance worth flagging is the intensified focus on AI and semiconductor capability, mirroring wider European concern over technological sovereignty. Investors in these areas should assume close scrutiny of any rights that grant access to the underlying technology, even from a small equity position. Communications from the Ministère de l’Économie provide useful signals on evolving priorities.

Enforcement, penalties and remedies

The French regime carries real teeth. Where a transaction is implemented without required authorisation, or where conditions are breached, the authority can order remedial measures. These include requiring the parties to restore the prior situation, in effect, unwinding the transaction, imposing conditions retroactively, and applying financial sanctions. In the most serious cases the state can direct a divestment of the acquired stake, and it can suspend the investor’s voting rights. Administrative fines are the primary financial exposure; the applicable ceilings are set by the Code monétaire et financier and should be verified against the current text.

The enforcement posture in recent years has been to prioritise substance over form and to scrutinise structures designed to conceal ultimate ownership or to disguise the acquisition of influence. For deal teams, the message is straightforward: a failure to notify is not a low‑visibility risk that can be managed after the fact. The penalty provisions in the Code monétaire et financier and the possibility of a divestment order make proactive analysis and, where required, notification the only defensible course.

Practical checklist for deal teams, a signing‑to‑closing playbook

The following playbook operationalises FDI screening minority investments france compliance across the deal lifecycle:

1. Pre‑deal screening. Map the target’s activities against the protected‑sector lists before drafting term sheets.
2. Investor structure analysis. Identify the ultimate beneficial owner and any concert parties; assess EU/EEA versus non‑EU status and apply the look‑through principle.
3. Rights audit. List every governance right the investor will hold and test each against the triggering indicia.
4. Red‑flag review. Flag board seats, vetoes, access to sensitive IP, convertible instruments and any concert‑action arrangements.
5. Preliminary engagement. Where scope is uncertain, use the Treasury’s preliminary‑request procedure early and assemble the information dossier.
6. SPA timetable. Build authorisation into the condition‑precedent architecture; set milestones for filing, review and clearance.
7. Long‑stop and break fee. Calibrate the long‑stop date and any reverse break fee to the assessed regulatory risk and expected review duration.
8. Interim governance. Impose standstill and firewall obligations to prevent premature implementation.
9. Local counsel liaison. Coordinate with French counsel and, through them, with the authority throughout the review.
10. Confidentiality and announcement strategy. Align public communications with the regulatory timetable to avoid signalling an unauthorised implementation.

For teams weighing whether specialist support is warranted, guidance on when do I need a cross‑border M&A lawyer in France provides a useful decision framework.

Conclusion, executive summary and next steps

FDI screening minority investments france is a substance test, not a percentage test: a non‑controlling stake is caught where it confers influence, access to sensitive assets, or exposure in a protected sector (and, for non‑EU/EEA investors, where a defined voting‑rights threshold in a listed company is crossed). As competition review reforms narrow the reach of merger control, foreign investment screening becomes an increasingly central regulatory gate for cross‑border minority investments in French strategic assets. The disciplined response is to map the sector first, audit the rights second, and draft the SPA, condition precedent, long‑stop, standstill and reverse break fee, to keep the deal alive through review without risking premature implementation.

Deal teams facing a minority investment in a sensitive French target should verify the current statutory thresholds and timelines against Legifrance and the Treasury before committing to a timetable, and seek local counsel early.

Sources

1. Code monétaire et financier (Legifrance)
2. Regulation (EU) 2019/452 (EUR‑Lex)
3. Direction générale du Trésor
4. OECD, Investment
5. Legifrance, Journal Officiel and implementing texts
6. Ministère de l’Économie